3 months AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq Investing.com

AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq.

AbbVie (ABBV)